Navigation Links
Nile Therapeutics Reports 2010 Second Quarter Financial Results
Date:8/16/2010

SAN MATEO, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its second quarter financial results for 2010.

Financial ResultsFor the three months ended June 30, 2010, Nile reported a net loss of approximately $1.5 million, or $0.05 per share, compared to a net loss of approximately $2.5 million, or $0.10 per share, during the second quarter of 2009. Weighted-average shares outstanding for the second quarter were 32.3 million.

Net cash used in operating activities in the second quarter of 2010 was approximately $1.0 million; net cash provided by financing activities was approximately $4.5 million; and net cash increase in the second quarter of 2010 was approximately $3.6 million. As of June 30, 2010, Nile had cash and cash equivalents of approximately $5.6 million compared to approximately $3.2 million as of December 31, 2009.

Update on CD-NPDuring June 2010, Nile completed enrolling a placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure ("ADHF") in the United States, Germany and Israel. In total, 77 patients were randomized into four doses of CD-NP (1.25, 2.5, 3.75 and 5 ng/kg/min) vs. placebo. The last patient visit occurred at the end of July and final results from the study are expected in the fourth quarter of 2010. Also in the fourth quarter of 2010, Nile plans to submit to the FDA for review and discussion, the clinical protocol for a double-blind, placebo controlled Phase IIb study of CD-NP in ADHF patients.

About Nile TherapeuticsNile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developin
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... following statement regarding the Medicare Part D offsets ... Century Cures initiative: "If the 21st Century ... billions from America,s premier health program – Medicare ... it may yield down the road. ...
(Date:5/21/2015)... -- Heidrick & Struggles (Nasdaq: HSII ), the premier ... and culture shaping worldwide, strengthens its ... the addition of Tim Dietlin to the ... Dietlin has extensive life sciences and professional services ... and Commercial functions to increase productivity, drive transformational change, ...
Breaking Medicine Technology:CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Heidrick Increases Healthcare and Life Sciences Expertise 2
... SAN DIEGO, December 6, 2011 Speaking ... Antibody Conference in San Diego, Dr. Klaus Schwamborn, CDO ... the discovery of therapeutic antibodies. In his ... technology and the most recent developments of immunogen design. ...
... N.J., Dec. 6, 2011   Unity Management Group, Inc. ... Metropolitan Computing Corporation (MCC) are pleased to announce the ... The contract is valued at $105,000. The ... designed for Roller Compactors. Michael Oliver, Vice President stated, ...
Cached Medicine Technology:Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference 2Unity Management Group, Inc. Receives Contract From Sun Pharmaceutical India's Largest Pharmaceutical Companies for $105,000 2Unity Management Group, Inc. Receives Contract From Sun Pharmaceutical India's Largest Pharmaceutical Companies for $105,000 3
(Date:5/23/2015)... 2015 On Wednesday, May 20, 2015, ... has been the target of a sophisticated cyberattack,” and ... company’s ongoing Information Technology (IT) security efforts in the ... The most notable attack on health insurers was reported ... nation’s second largest health insurer, revealed that they had ...
(Date:5/23/2015)... IL (PRWEB) May 23, 2015 A live ... medical equipment from hospitals, surgery centers and other medical facilities ... be sold including endoscopy, lab, radiology, surgery, anesthesia, exam and ... Wednesday, May 27 and Thursday, May 28 starting at 9:00am ... located at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on the ... legislature but which has not been signed to date by ... 449 with overwhelming bipartisan support on April 10, 2015, ... This bill ensures that fracking is prohibited in Maryland through ... of fracking to our water supplies and the air we ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... New York, New York (PRWEB) May 22, 2015 ... ( http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals ... complications due to its use continue to move ... of Louisiana. According to a Pretrial Order dated ... governing the preservation of documents and electronically stored ...
Breaking Medicine News(10 mins):Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4
... could offer new treatments for other autoimmune disorders, study ... believe they have finally answered a basic question about ... body does the wheat protein gluten enter one,s system? ... Gastroenterology identifies the CXCR3 receptor in the ...
... July 24 Tepha, Inc., a developer of,medical ... polymers, announced,today that it has appointed John Hartnett ... Chief Operating Officer. Mr. Hartnett joins Tepha,following an ... he,progressed from field sales, to marketing management, and, ...
... (Becton,Dickinson and Company) (NYSE: BDX ) today reported ... quarter ended June 30, 2008,representing an increase of 14.5 ... rate reflects the favorable impact on all segments,from foreign ... 7 percentage points of the increase in quarterly revenues., ...
... Cancellations and Higher Operating Costs to Affect ... ... 7, 2008, DENVER, July 24 Air Methods Corporation,(Nasdaq: ... an update on second quarter 2008 results., Based on preliminary ...
... alliance of animal,lovers is attacking one of America,s most ... America is struggling with a weight problem. About ... Unfortunately, our pets -- they really,do look like us ... Campaign to End Obesity, a public/private partnership that includes,Harvard ...
... for its module cleanrooms. The feature is a utility panel ... cleanroom appearance. , ... Burnsville, Minn. (PRWEB) July 24, ... systems, announced today that they are now offering a utility panel ...
Cached Medicine News:Health News:Intestinal Gluten Receptor Is Gateway for Celiac Disease 2Health News:Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer 2Health News:BD Announces Results for Third Fiscal Quarter 2Health News:BD Announces Results for Third Fiscal Quarter 3Health News:BD Announces Results for Third Fiscal Quarter 4Health News:BD Announces Results for Third Fiscal Quarter 5Health News:BD Announces Results for Third Fiscal Quarter 6Health News:BD Announces Results for Third Fiscal Quarter 7Health News:BD Announces Results for Third Fiscal Quarter 8Health News:BD Announces Results for Third Fiscal Quarter 9Health News:BD Announces Results for Third Fiscal Quarter 10Health News:BD Announces Results for Third Fiscal Quarter 11Health News:BD Announces Results for Third Fiscal Quarter 12Health News:BD Announces Results for Third Fiscal Quarter 13Health News:BD Announces Results for Third Fiscal Quarter 14Health News:BD Announces Results for Third Fiscal Quarter 15Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 2Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 3Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 4Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2
Inquire...
... Axiovert 40 inverted ... you have ever expected from a microscope in ... outstanding quality, and functionality. Axiovert 40 has been ... safe as possible thus increasing the efficiency ...
... The Eclipse TE2000S is ... live cell research. It's exclusive ... resolution with high numerical aperatures ... the first inverted microscope to ...
... IX71's modular frame and ... access ports for multiple ... Up to four ports ... to a primary image. ...
Medicine Products: